News section
Australian Gene Technology Regulator issues licence to Dow AgroSciences Australia for limited and controlled release of three GM insecticidal/herbicide tolerant cotton lines
Woden, ACT, Australia
May 28, 2004
 

DECISION ON ISSUING A LICENCE FOR APPLICATION DIR 044/2003 
http://www.health.gov.au/ogtr/ir/dir044.htm

DIR 044/2003 Dow AgroSciences Australia Pty Ltd Agronomic assessment and seed increase of transgenic cottons expressing insecticidal genes (cry1Ac and cry1Fa) from Bacillus thuringiensis Cotton Gossypium hirsutum L Insecticidal and herbicide tolerance 28-May-2004 Current

The Office of the Gene Technology Regulator (the Regulator) has made a decision to issue a licence in respect of application DIR 044/2003 from Dow AgroSciences Australia Limited.  The application requested approval to undertake a limited and controlled release of three genetically modified (GM) insecticidal/herbicide tolerant cotton lines on up to 30 sites covering a total area of 12.2 hectares in New South Wales, Queensland and Western Australia over four cotton growing seasons (two summer and two winter, 2004-2006).

The decision to issue the licence was made after extensive consultation on the Risk Assessment and Risk Management Plan (RARMP) with the public, State and Territory governments, Australian Government agencies, the Minister for the Environment and Heritage, the Gene Technology Technical Advisory Committee and the relevant local councils, as required by the Gene Technology Act 2000.

Issues relating to the health and safety of people and the protection of the environment raised during the consultation process on this application were considered in finalising the RARMP and in making a decision on whether to issue the licence.

The licence has been issued with specific licence conditions that will ensure effective implementation of the risk management plan.  The specific conditions include containment measures, restrictions on the use of the GM cottonseed, research requirements and post-harvest cleaning and monitoring of the trial sites. 

The Executive Summary and the complete finalised RARMP, together with the licence conditions, can be obtained on-line from the Office of the Gene Technology Regulator’s website or at the address below.

Office of the Gene Technology Regulator
MDP 54, PO Box 100
WODEN  ACT  2606

Telephone: 1800 181 030
Facsimile: 02 6271 4202
http://www.ogtr.gov.au

News release

Other news from this source

8835

Back to main news page

The news release or news item on this page is copyright © 2004 by the organization where it originated.
The content of the SeedQuest website is copyright © 1992-2004 by
SeedQuest - All rights reserved
Fair Use Notice